CVR: 44308622
Linker Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Nils Aage Brünner and Kasper Pasternak Jørgensen. The company is owned by Resistance Oncology ApS. In 2025, the company reported a gross profit of DKK -341,305 and a net result of DKK -268,417. Equity amounted to DKK 57,244.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileUdvikle og kommercialisere pharmaceutiske produkter.
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Linker Pharmaceuticals ApS has published its annual report for 2025. Gross profit came to DKK -341,305, and the net result was DKK -268,417.
Contact info changed: new email: [email protected] (January 12, 2026).
As of August 19, 2025, Resistance Oncology ApS is registered as an owner of Linker Pharmaceuticals ApS with an ownership share of 100%.
Linker Pharmaceuticals ApS has published its interim report for the period September 15, 2023 – December 31, 2024.
As of September 15, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Linker Pharmaceuticals ApS.
As of September 15, 2023, Nils Aage Brünner is registered as adm. dir. of Linker Pharmaceuticals ApS.
As of September 15, 2023, Kasper Pasternak Jørgensen is registered as director of Linker Pharmaceuticals ApS.
Linker Pharmaceuticals ApS was founded on September 15, 2023.
Companies in the same industry and area
CVR 45984842
CVR 34668272
CVR 45663205
CVR 44714922
CVR 33871902
companydata.dk